Reference is made to the notice on 29 August 2024 regarding settlement of a term payment on a convertible loan by issue of 9,123,333 shares at NOK 0.60 per share. The share capital has been registered and the shares will be delivered soonest. Following the issue, the company's share capital is NOK 50,812,483.20 divided into 338,749,888 shares, each with a nominal value of NOK 0.15. For further information contact:Marianne Bøe, Investor RelationsE-mail: marianne.boe@idexbiometrics.comTel: +47 918 00186 Ab ...